W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Position of the Transparency Council

Position of the Transparency Council – Milupa Basic-P

more...

Position of the Transparency Council – Ospolot (sultiam)

more...

Position of the Transparency Council – Jardiance (empagliflozyna)

more...

Position of the Transparency Council – Yervoy (ipilimumab)

more...

Position of the Transparency Council – Opdivo (niwolumab)

more...

Position of the Transparency Council – Tremfya (guselkumabum)

more...

Position of the Transparency Council – Inovelon (rufinamide)

more...

Position of the Transparency Council – Fycompa (perampanel)

more...

Position of the Transparency Council – Ozurdex (dexamethasone)

more...

Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of retinoblastoma or von Hippel-Lindau (VHL) disease” as a guaranteed health care service

more...

Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of colorectal cancer or endometrial cancer” as a guaranteed health care service

more...

Position of the Transparency Council – qualifying the health care service “Care for families at high hereditary risk of breast or ovarian cancer” as a guaranteed health care service

more...

Position of the Transparency Council – qualifying the health care service “Colorectal cancer screening programme” as a guaranteed health care service

more...